Thuja Capital is a venture capital and private equity firm investing in early-stage medical technology and healthcare companies that is headquartered in Utrecht, Netherlands and was founded in 2006 by Harrold van Barlingen.
Thuja Capital has made 40 investments, 30 lead investments, and 14 exits. Notable investments made by Thuja Capital include: arGEN-X, Galapagos, Avantium Technologies, Enanta Pharmaceuticals, Nightbalance, Bioceros, Omrix Biopharmacetuicals, Coley Pharmaceutical Group, Vernalis, Intercell, Mellon Medical, Salvia BioElectronics, Encare Biotech, Cytura, Fabulous, and Coley.
Avantium Technologies is an Amsterdam-based manufacturing company offering research and development for products and applications in the energy, chemicals, and pharmaceuticals industry.
DCPrime is a biotechnology company developing cancer immunotherapies.
A company developing and marketing diagnostic and therapeutic anti-viral products for domesticated animals
Cristal Therapeutics is a Maastricht-based clincial stage pharmaceutical company developing targeted nanomedicines founded in 2011.